ClearPoint Neuro, Inc. (CLPT) Stock Analysis — Probabli.AI
AI-powered analysis for CLPT (ClearPoint Neuro, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $10.56 · Market cap: $295.6M · AI outlook: Bullish
ClearPoint Neuro, Inc. (NASDAQ: CLPT) occupies a critical niche at the intersection of medical robotics, intraoperative MRI navigation, and CNS-targeted biologic delivery. Despite recent headline pressure stemming from partner trial results and quarterly earnings volatility, CLPT presents a highly asymmetrical risk/reward profile. Supported by an estimated 55.7% top-line growth trajectory and a…
Probabilistic 1-Year Outlook
- Bull 55% · Neutral 25% · Bear 20%
- 1-year price estimates — P10: $7 / P50: $16 / P90: $26
- ClearPoint Neuro trades at an attractive entry valuation relative to its high-growth neuro-navigation and biologics delivery pipeline. Strong projected top-line revenue growth exceeding 50% and bullish analyst targets…
5-Year Outlook
- Bull 60% · Neutral 22% · Bear 18%
- 5-year price estimates — P10: $7 / P50: $34 / P90: $62
SWOT Highlights
- Strength: Proprietary MRI-guided navigation platform enabling real-time direct CNS drug delivery
- Strength: Extensive network of over 50 biopharma drug delivery partnerships for CNS gene therapies
- Risk: Ongoing negative net margins and continuous cash burn requiring potential equity dilution
- Risk: High dependence on clinical development timelines and success rates of external biopharma partners
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
2 Wall Street analysts rate CLPT a STRONG BUY with a mean price target of $27.5.
Last analyzed · Model: gemini-3.8-flash. How this forecast works · Accuracy & validation.
CLPT forecast details · CLPT sentiment details
Recent saved forecast research
AI-generated research records, not evaluated investment results.
- ClearPoint Neuro, Inc. (CLPT) — saved
ClearPoint Neuro, Inc. (NASDAQ: CLPT) occupies a critical niche at the intersection of medical robotics, intraoperative MRI navigation, and CNS-targeted biologic delivery. Despite recent headline pressure stemming from partner trial results
- ClearPoint Neuro, Inc. (CLPT) — saved
ClearPoint Neuro, Inc. is positioned as an innovator in the neurotechnology space with potential for recovery and growth through strategic initiatives. Despite recent market challenges, the company's fundamental investments in technology an
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.